{"filing": {"accession": "0001493152-26-036978", "cik": "0001933567", "ticker": "NRXS", "company_name": "Neuraxis, INC", "form_type": "10-Q", "filing_type": "10-Q", "filing_date": "2026-08-11", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/0001493152-26-036978-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/0001493152-26-036978-index.htm", "period_of_report": "2026-06-30"}, "html_url": "/api/filings/000149315226036978/stream", "exhibits": [{"exhibit_number": "31.1", "exhibit_type": "31", "description": "Certification pursuant to 18 U.S.C. Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer", "filename": "ex31-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/ex31-1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.2", "exhibit_type": "31", "description": "Certification pursuant to 18 U.S.C. Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer", "filename": "ex31-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/ex31-2.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32.1", "exhibit_type": "32", "description": "Certification pursuant to 18 U.S.C. Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer", "filename": "ex32-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/ex32-1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32.2", "exhibit_type": "32", "description": "Certification pursuant to 18 U.S.C. Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer", "filename": "ex32-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1933567/000149315226036978/ex32-2.htm", "category": "other", "incorporated_by_reference": false}], "sections": [{"section_name": "part_1_item_1", "section_title": ":", "start_position": 3744, "end_position": 81219}, {"section_name": "part_1_item_2", "section_title": ":", "start_position": 81219, "end_position": 100229}, {"section_name": "part_1_item_3", "section_title": ":", "start_position": 100229, "end_position": 100321}, {"section_name": "part_1_item_4", "section_title": ":", "start_position": 100321, "end_position": 104200}, {"section_name": "part_2_item_1", "section_title": ":", "start_position": 104200, "end_position": 106814}, {"section_name": "part_2_item_1a", "section_title": ":", "start_position": 106814, "end_position": 107209}, {"section_name": "part_2_item_2", "section_title": ":", "start_position": 107209, "end_position": 107285}, {"section_name": "part_2_item_3", "section_title": ":", "start_position": 107285, "end_position": 107334}, {"section_name": "part_2_item_4", "section_title": ":", "start_position": 107334, "end_position": 107384}, {"section_name": "part_2_item_5", "section_title": ":", "start_position": 107384, "end_position": 107694}, {"section_name": "part_2_item_6", "section_title": ":", "start_position": 107694, "end_position": 109308}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware45-5079684"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "11611\n N. Meridian Street,Suite 330Carmel,IN46032"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "Title\n of each classTrading\n Symbol(s)Name\n of each exchange on which registered"}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": "Large\n accelerated filer \u2610Accelerated\n filer \u2610"}, {"table_index": 5, "table_type": "financial", "caption": null, "header_text": "PART I3"}, {"table_index": 8, "table_type": "financial", "caption": null, "header_text": "June 30, 2026December 31, 2025"}, {"table_index": 11, "table_type": "financial", "caption": null, "header_text": "2026202520262025"}, {"table_index": 14, "table_type": "text", "caption": null, "header_text": "SharesAmountSharesAmountCapitalDeficitEquity"}, {"table_index": 17, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 20, "table_type": "text", "caption": null, "header_text": "\u25cfThe\n IB-STIM is a percutaneous electrical nerve field stimulator (PENFS) device that is indicated in patients 8-21 years of age with functional\n abdominal pain associated with irritable bowel syndrom"}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "20262025"}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": "2026202520262025"}, {"table_index": 33, "table_type": "text", "caption": null, "header_text": "\u25cfRefund\n the price paid for any defective or nonconforming products."}, {"table_index": 38, "table_type": "financial", "caption": null, "header_text": "June 30, 2026December 31, 2025"}, {"table_index": 41, "table_type": "financial", "caption": null, "header_text": "June 30, 2026December 31, 2025"}, {"table_index": 42, "table_type": "financial", "caption": null, "header_text": "June 30, 2026December 31, 2025"}, {"table_index": 45, "table_type": "text", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 46, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 49, "table_type": "text", "caption": null, "header_text": "Number ofWeighted-Avg.Weighted-Avg."}, {"table_index": 50, "table_type": "text", "caption": null, "header_text": "Number of"}, {"table_index": 53, "table_type": "text", "caption": null, "header_text": "Six Months Ended June 30,"}, {"table_index": 54, "table_type": "text", "caption": null, "header_text": "Number of OptionsWeighted Avg. Remaining Contractual Life (in years)Weighted Avg. Exercise PriceAggregate Intrinsic Value"}, {"table_index": 57, "table_type": "financial", "caption": null, "header_text": "Level 3"}, {"table_index": 60, "table_type": "financial", "caption": null, "header_text": "2026202520262025"}, {"table_index": 61, "table_type": "financial", "caption": null, "header_text": "(a)The\n significant expense categories and amounts align with the segment-level information provided on a regular basis to the CODM."}, {"table_index": 70, "table_type": "financial", "caption": null, "header_text": "(Unaudited)(Unaudited)"}, {"table_index": 75, "table_type": "text", "caption": null, "header_text": "(Unaudited)"}, {"table_index": 78, "table_type": "text", "caption": null, "header_text": "\u25cfIneffective\n approval processes governing (i) timely Board of Directors authorization and (ii) segregation of duties and roles and responsibilities\n configurations within the Company\u2019s financial repo"}, {"table_index": 83, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit"}, {"table_index": 86, "table_type": "text", "caption": null, "header_text": "NEURAXIS,\n INC."}, {"table_index": 87, "table_type": "text", "caption": null, "header_text": "Date:\n August 11, 2026/s/\n Timothy Henrichs"}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 34}